BRPI0821922A2 - Derivado esteroide de gama-lactona de ácido 17-hidróxi-19-nor-21-carboxílico, uso do mesmo e medicamento que contém o derivado - Google Patents

Derivado esteroide de gama-lactona de ácido 17-hidróxi-19-nor-21-carboxílico, uso do mesmo e medicamento que contém o derivado

Info

Publication number
BRPI0821922A2
BRPI0821922A2 BRPI0821922-2A BRPI0821922A BRPI0821922A2 BR PI0821922 A2 BRPI0821922 A2 BR PI0821922A2 BR PI0821922 A BRPI0821922 A BR PI0821922A BR PI0821922 A2 BRPI0821922 A2 BR PI0821922A2
Authority
BR
Brazil
Prior art keywords
derivative
hydroxy
carboxylic acid
drug containing
acid gamma
Prior art date
Application number
BRPI0821922-2A
Other languages
English (en)
Inventor
Ulrich Klar
Joachim Kuhnke
Rolf Bohlmann
Jan Hübner
Sven Ring
Thomas Frenzel
Frederik Menges
Steffen Borden
Hans Peter Muhn
Katja Prelle
Original Assignee
Bayer Schering Pharma Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Bayer Schering Pharma Ag filed Critical Bayer Schering Pharma Ag
Publication of BRPI0821922A2 publication Critical patent/BRPI0821922A2/pt

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J53/00—Steroids in which the cyclopenta(a)hydrophenanthrene skeleton has been modified by condensation with a carbocyclic rings or by formation of an additional ring by means of a direct link between two ring carbon atoms, including carboxyclic rings fused to the cyclopenta(a)hydrophenanthrene skeleton are included in this class
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/12—Drugs for genital or sexual disorders; Contraceptives for climacteric disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/18—Feminine contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/24—Drugs for disorders of the endocrine system of the sex hormones
    • A61P5/26—Androgens
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/24—Drugs for disorders of the endocrine system of the sex hormones
    • A61P5/30—Oestrogens
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/24—Drugs for disorders of the endocrine system of the sex hormones
    • A61P5/34—Gestagens
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/38—Drugs for disorders of the endocrine system of the suprarenal hormones
    • A61P5/42—Drugs for disorders of the endocrine system of the suprarenal hormones for decreasing, blocking or antagonising the activity of mineralocorticosteroids
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J19/00—Normal steroids containing carbon, hydrogen, halogen or oxygen, substituted in position 17 by a lactone ring
BRPI0821922-2A 2007-12-29 2008-12-23 Derivado esteroide de gama-lactona de ácido 17-hidróxi-19-nor-21-carboxílico, uso do mesmo e medicamento que contém o derivado BRPI0821922A2 (pt)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE102007063503A DE102007063503A1 (de) 2007-12-29 2007-12-29 17-Hydroxy-19-nor-21-carbonsäure-Steroid y-Lacton-Derivat, dessen Verwendung und das Derivat enthaltende Arzneimittel
PCT/EP2008/011159 WO2009083266A1 (de) 2007-12-29 2008-12-23 17-hydroxy-19-nor-21-carbonsäure-steroid y-lacton-derivat, dessen verwendung und das derivat enthaltende arzneimittel

Publications (1)

Publication Number Publication Date
BRPI0821922A2 true BRPI0821922A2 (pt) 2015-06-16

Family

ID=40481980

Family Applications (1)

Application Number Title Priority Date Filing Date
BRPI0821922-2A BRPI0821922A2 (pt) 2007-12-29 2008-12-23 Derivado esteroide de gama-lactona de ácido 17-hidróxi-19-nor-21-carboxílico, uso do mesmo e medicamento que contém o derivado

Country Status (22)

Country Link
US (1) US8937058B2 (pt)
EP (1) EP2238151A1 (pt)
JP (1) JP5600068B2 (pt)
KR (1) KR20100102688A (pt)
CN (1) CN101910190A (pt)
AR (1) AR069966A1 (pt)
AU (1) AU2008342910A1 (pt)
BR (1) BRPI0821922A2 (pt)
CA (1) CA2710491C (pt)
CL (1) CL2008003918A1 (pt)
CO (1) CO6300845A2 (pt)
CR (1) CR11545A (pt)
DE (1) DE102007063503A1 (pt)
DO (1) DOP2010000198A (pt)
EC (1) ECSP10010318A (pt)
IL (1) IL206379A0 (pt)
PA (1) PA8809701A1 (pt)
PE (1) PE20091362A1 (pt)
TW (1) TW200940073A (pt)
UY (1) UY31584A1 (pt)
WO (1) WO2009083266A1 (pt)
ZA (1) ZA201005396B (pt)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE102007063503A1 (de) 2007-12-29 2009-07-02 Bayer Schering Pharma Aktiengesellschaft 17-Hydroxy-19-nor-21-carbonsäure-Steroid y-Lacton-Derivat, dessen Verwendung und das Derivat enthaltende Arzneimittel
WO2012059594A1 (en) 2010-11-04 2012-05-10 Bayer Pharma Aktiengesellschaft Mineralcorticoid receptor antagonists for the treatment of corticoid-induced obesity

Family Cites Families (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2918463A (en) 1958-06-12 1959-12-22 Searle & Co 17-carboxyalkylated 17-hydroxy-19-norandrosten-3-ones
US3194803A (en) * 1960-04-28 1965-07-13 Searle & Co Process and intermediates for the manufacture of 3-keto-delta4, 6 steroids
US3254074A (en) * 1962-04-25 1966-05-31 Merck & Co Inc Spiroxenones
DE1183500B (de) 1962-10-12 1964-12-17 Schering Ag Verfahren zur Herstellung von alpha, beta-Methylenketonen der Steroidreihe
US3705179A (en) 1971-03-15 1972-12-05 American Home Prod Antiandrogenic steroids
US3764596A (en) * 1971-06-22 1973-10-09 Sandoz Ag 17-dihydrofuranyl-substituted steroids
NL7701384A (nl) 1977-02-10 1978-08-14 Akzo Nv Werkwijze voor het bereiden van nieuwe steroiden van de oestraanreeks.
DE2922500A1 (de) 1979-05-31 1980-12-04 Schering Ag 6 beta .7 beta
DE3022337A1 (de) 1980-06-11 1982-01-07 Schering Ag Berlin Und Bergkamen, 1000 Berlin Praeparate zur kontrazeption und zur behandlung gynaekologischer stoerungen
JPS59139400A (ja) * 1983-01-31 1984-08-10 Shionogi & Co Ltd 抗アルドステロン活性ステロイド誘導体
DE3402329A1 (de) 1984-01-20 1985-08-01 Schering AG, 1000 Berlin und 4709 Bergkamen 6,6-ethylen-15,16-methylen-3-oxo-17(alpha)-pregn-4-en-21,17-carbolactone, verfahren zu deren herstellung und diese enthaltende pharmazeutische praeparate
DE3410880A1 (de) * 1984-03-21 1985-10-03 Schering AG, Berlin und Bergkamen, 1000 Berlin 17-substituierte estradiene und estratriene
DE3426771C2 (de) 1984-07-07 1997-03-20 Schering Ag 13alpha-Methylgonane, deren Herstellung und Verwendung
DE4232521A1 (de) 1992-09-22 1994-03-24 Schering Ag Gestagen wirksame 4,5;11,12-Estradiene, Verfahren zu ihrer Herstellung, diese Estradiene enthaltende Arzneimittel sowie deren Verwendung zur Herstellung von Arzneimitteln
DE4447401A1 (de) 1994-12-23 1996-07-04 Schering Ag 14,17-C¶2¶-überbrückte Steroide
DE19651000A1 (de) 1996-12-01 1998-06-04 Schering Ag Oxyiminopregnancarbolactone
DE102004063864A1 (de) 2004-12-30 2006-07-13 Schering Ag 18-Methyl-19-nor-17-pregn-4-en21,17-carbolactone, sowie diese enthaltende pharmazeutische Präparate
DE102007063503A1 (de) 2007-12-29 2009-07-02 Bayer Schering Pharma Aktiengesellschaft 17-Hydroxy-19-nor-21-carbonsäure-Steroid y-Lacton-Derivat, dessen Verwendung und das Derivat enthaltende Arzneimittel

Also Published As

Publication number Publication date
CN101910190A (zh) 2010-12-08
AR069966A1 (es) 2010-03-03
EP2238151A1 (de) 2010-10-13
PA8809701A1 (es) 2009-07-23
DE102007063503A1 (de) 2009-07-02
KR20100102688A (ko) 2010-09-24
US20110021472A1 (en) 2011-01-27
UY31584A1 (es) 2009-08-03
AU2008342910A1 (en) 2009-07-09
CA2710491C (en) 2015-11-03
JP2011507924A (ja) 2011-03-10
CR11545A (es) 2010-08-27
US8937058B2 (en) 2015-01-20
JP5600068B2 (ja) 2014-10-01
ECSP10010318A (es) 2010-08-31
ZA201005396B (en) 2012-01-25
CL2008003918A1 (es) 2010-01-15
CO6300845A2 (es) 2011-07-21
WO2009083266A1 (de) 2009-07-09
IL206379A0 (en) 2010-12-30
DOP2010000198A (es) 2010-08-31
CA2710491A1 (en) 2009-07-09
PE20091362A1 (es) 2009-10-15
TW200940073A (en) 2009-10-01

Similar Documents

Publication Publication Date Title
BRPI0815190A2 (pt) Composto derivado de piridina, composição farmacêutica que o compreende e uso do mesmo
BRPI0814593A2 (pt) Composto, composição farmacêutica que o contém e uso do composto.
BRPI0918502A2 (pt) aminoindanos substituídos e análogos dos mesmos, e o uso farmacêutico dos mesmos
BRPI0821004A2 (pt) Composto derivado de aminopirazol, composição farmacêutica que o contem e uso deste
BRPI0821115A2 (pt) Composto derivado de aminotriazol, medicamento, composição farmacêutica e uso do composto
CL2007003470A1 (es) Compuestos derivados de urea; composicion farmaceutica que comprende a dichos compuestos; y su uso como antibacterianos.
BRPI0813455A2 (pt) Derivado de 17beta-ciano-18a-homo-19-nor-androst-4-eno, seu uso e medicamentos contendo este derivado.
BRPI0809667A2 (pt) Composto, medicamento e composição farmacêutica que o contém e uso do composto
DK3421471T3 (da) Purin- og deazapurinderivater som farmaceutiske forbindelser
BRPI0907892A2 (pt) Composto antibiótico azatricíclico, medicamento, composição farmacêutica que o contém e uso do mesmo
BRPI0720124A2 (pt) Composições farmacêuticas e seus métodos de uso.
BRPI0917315A2 (pt) anticorpo, composicao farmaceutico, e, uso de uma composicao farmaceutica
BRPI0810696A2 (pt) Composto, composição farmacêutica, e, uso de um composto
BRPI0908208A2 (pt) Composto derivado de oxazolidinona, medicamento, composição farmacêutica que o contém e uso desse composto.
CL2007002377A1 (es) Compuestos derivados de quinazolina; procedimiento de preparacion; composicion farmaceutica; y su uso como anticancerigeno.
BRPI0915120A2 (pt) composto derivado de oxima, uso do referido composto e composição farmacêutica
BRPI0917579A2 (pt) composto, composição farmacêutica, métodos, e, uso de um composto
CR10725A (es) Compuestos de pirazolina y su uso y composiones farmaceuticas
BRPI0917661A2 (pt) produto que contém macitentan, composição farmacêutica que o contém e uso de macitentan
BRPI0810399A2 (pt) Composto, composição farmacêutica que o contém e uso do mesmo
BRPI0807078A2 (pt) Composto, e, formulação farmacêutica
BRPI0810019A2 (pt) Composto, composição farmacêutica, e, uso de um composto
BRPI0717369A2 (pt) Composto, medicamento, composição farmacêutica que o contém e uso do composto.
BRPI0916571A2 (pt) composto derivado de alquilaminometiloxazolidinona tricíclo, medicamento e composição farmacêutica que o contém e uso do composto
BRPI0820985A2 (pt) Composto derivado de 5-aminociclometil-oxazondin-2-ona, medicamento e composição farmacêutica que os contém e uso dos mesmos

Legal Events

Date Code Title Description
B08F Application dismissed because of non-payment of annual fees [chapter 8.6 patent gazette]

Free format text: REFERENTE AS 3A, 4A, 5A, 6A E 7A ANUIDADES.

B08K Patent lapsed as no evidence of payment of the annual fee has been furnished to inpi [chapter 8.11 patent gazette]

Free format text: EM VIRTUDE DO ARQUIVAMENTO PUBLICADO NA RPI 2343 DE 01-12-2015 E CONSIDERANDO AUSENCIA DE MANIFESTACAO DENTRO DOS PRAZOS LEGAIS, INFORMO QUE CABE SER MANTIDO O ARQUIVAMENTO DO PEDIDO DE PATENTE, CONFORME O DISPOSTO NO ARTIGO 12, DA RESOLUCAO 113/2013.